TG Therapeutics, Inc. (TGTX) Revenue Breakdown by Product - Discounting Cash Flows
TGTX
TG Therapeutics, Inc.
TGTX (NASDAQ)
Period Ending: 2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
Total
1234
License Revenue
1234
License Revenue (%)
1234
Other Revenue
1234
Other Revenue (%)
1234
Product
1234
Product (%)
1234
Royalty
1234
Royalty (%)
1234
Milestone
1234
Milestone (%)
1234
License revenue
1234
License revenue (%)
1234
Product revenue, net
1234
Product revenue, net (%)
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program